Citation

England KS, Tumber A, Krojer T, Scozzafava G, Ng SS, Daniel M, Szykowska A, Che K, von Delft F, Burgess-Brown NA, Kawamura A, Schofield CJ, Brennan PE.: Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. Medchemcomm, Volume 5 (12), 2014

Authors

Brennan PE., Burgess-Brown NA, Che K, Daniel M, England KS, Kawamura A, Krojer T, Ng SS, Schofield CJ, Scozzafava G, Szykowska A, Tumber A, von Delft F

Journal

Medchemcomm

Year

2014

DOI

10.1039/c4md00291a

PubMed

26682034

Machine-readable

REST APIRDF